Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapy

BACKGROUND: During the last few years it has been shown in several laboratories that Celecoxib (Cx), a non-steroidal anti-inflammatory agent (NSAID) normally used for pain and arthritis, mediates antitumor and antiangiogenic effects. However, the effects of this drug on a tumor cell line resistant t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosas, Carlos, Sinning, Mariana, Ferreira, Arturo, Fuenzalida, Marcela, Lemus, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101715/
https://www.ncbi.nlm.nih.gov/pubmed/25027008
http://dx.doi.org/10.1186/0717-6287-47-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101715/
https://www.ncbi.nlm.nih.gov/pubmed/25027008
http://dx.doi.org/10.1186/0717-6287-47-27

Ejemplares similares